"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
Descriptor ID |
D045744
|
MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 2 | 121 | 123 |
2004 | 1 | 305 | 306 |
2005 | 1 | 315 | 316 |
2006 | 6 | 296 | 302 |
2007 | 1 | 374 | 375 |
2008 | 3 | 354 | 357 |
2009 | 4 | 391 | 395 |
2010 | 2 | 415 | 417 |
2011 | 3 | 450 | 453 |
2012 | 2 | 407 | 409 |
2013 | 3 | 406 | 409 |
2014 | 1 | 428 | 429 |
2015 | 3 | 405 | 408 |
2016 | 0 | 425 | 425 |
2017 | 0 | 364 | 364 |
2018 | 1 | 335 | 336 |
2019 | 2 | 324 | 326 |
2020 | 0 | 279 | 279 |
2021 | 0 | 262 | 262 |
2022 | 0 | 123 | 123 |
2023 | 0 | 108 | 108 |
2024 | 0 | 25 | 25 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
Identification of Colorectal Cancer Cell Stemness from Single-Cell RNA Sequencing. Mol Cancer Res. 2024 Apr 02; 22(4):337-346.
-
Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy. J Med Chem. 2024 Apr 11; 67(7):5333-5350.
-
Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. Nat Commun. 2024 Mar 19; 15(1):2461.
-
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells. Oncotarget. 2024 Mar 14; 15:220-231.
-
Nutrient scavenging-fueled growth in pancreatic cancer depends on caveolae-mediated endocytosis under nutrient-deprived conditions. Sci Adv. 2024 Mar; 10(9):eadj3551.
-
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer. BMC Cancer. 2024 Feb 19; 24(1):233.
-
CD24 negativity reprograms mitochondrial metabolism to PPARa and NF-?B-driven fatty acid ?-oxidation in triple-negative breast cancer. Cancer Lett. 2024 Apr 10; 587:216724.
-
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. RNA. 2024 Feb 16; 30(3):281-297.
-
Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Sci Adv. 2024 Feb 16; 10(7):eadk1835.
-
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nat Commun. 2024 Feb 14; 15(1):1373.